Skip to main content
Ambuja Cements Ltd. logo

Ambuja Cements Ltd. — Investor Relations & Filings

Ticker · AMBUJACEM ISIN · INE079A01024 LEI · 335800NT6LQHR1428E20 BSE.NS Manufacturing
Filings indexed 2,524 across all filing types
Latest filing 2025-11-03 Regulatory Filings
Country IN India
Listing BSE.NS AMBUJACEM

About Ambuja Cements Ltd.

https://www.ambujacement.com/

Ambuja Cements Ltd. is a major manufacturer of cement and building materials. The company specializes in producing Ordinary Portland Cement (OPC) and Pozzolana Portland Cement (PPC), catering to diverse construction needs across residential, commercial, and infrastructure sectors. Its product portfolio includes specialized solutions such as Ambuja Plus, Ambuja Kawach, and Ambuja Cool Walls, designed for enhanced durability and environmental resistance. The organization emphasizes sustainable development through initiatives focused on water positivity, plastic negativity, and reduced carbon emissions. Utilizing advanced manufacturing technologies and a robust distribution network, the company provides high-strength building materials tailored for various climatic conditions. Now a key entity within the Adani Group, it continues to focus on operational efficiency and innovative construction solutions.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the submission of an audio recording of an analysts/investors call related to the unaudited financial results for the quarter and half year ended 30th September 2025. It references an audio recording and a web link to the recording, not the transcript itself. The document length is short (1430 characters), and it does not contain the actual transcript or detailed financial data. Therefore, it is not a Call Transcript (CT) but rather an announcement or submission notice related to the call. Given the nature of the document as a notification of the availability of the audio recording, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other categories.
2025-11-03 English
Statement of deviation(s) or variation(s) under Reg. 32
Regulatory Filings Classification · 95% confidence The document is a submission to stock exchanges regarding the statement of deviation or variation in the utilization of funds raised through a preferential issue of equity shares. It references Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and provides details for the quarter ended September 30, 2025. The content includes a statement reviewed by the Audit Committee and signed by the Company Secretary, confirming no deviations or variations in the use of proceeds. The document is a regulatory compliance filing related to fund utilization and does not contain financial statements or detailed financial performance data. It is not an annual or interim report, earnings release, or audit report. It is also not a report publication announcement since it contains substantive information rather than just a notice. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2025-11-03 English
Statement of Deviation for the quarter ended 30th September 2025
Regulatory Filings
2025-11-03 English
The Company has informed the exchange regarding Investor Presentation.
Regulatory Filings
2025-11-03 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is titled as an 'Investor Presentation' and is addressed under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, which typically governs disclosures to stock exchanges. The content includes detailed operational and financial highlights for the quarter and half year ended 30th September 2025, including revenue, EBITDA, capacity expansion plans, strategic initiatives, and ESG updates. It also contains charts, figures, and strategic outlooks, which are typical of investor presentations aimed at providing comprehensive financial and operational insights to investors. The document is about 15,000 characters long, indicating it is a full presentation rather than a brief announcement. There is no indication that this is a full annual or quarterly report with formal financial statements, nor is it a transcript, audit report, or regulatory filing. Therefore, the document best fits the category of an Investor Presentation (IP).
2025-11-03 English
The Company had informed the exchange regarding a press release dated 03rd November, 2025 titled " Ambuja Cements achieves robust Q2 FY 26 Performance".
Regulatory Filings
2025-11-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.